EL625
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EL625, covering 2012-08-22 to 2014-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML [Phase 2]